Sumitomo Mitsui Trust Group, Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for ADAPTIVE BIOTECHNOLOGIES CORPORATION Common stock, par value $0.0001 per share (ADPT)

Filing Manager
Sumitomo Mitsui Trust Group, Inc.
Reporting Manager
Sumitomo Mitsui Trust Group, Inc.
Security
ADAPTIVE BIOTECHNOLOGIES CORPORATION Common stock, par value $0.0001 per share
Symbol
ADPT
Shares outstanding
148,546,457 shares
Disclosed Ownership
6,833,137 shares
Ownership
4.6%
Form type
SCHEDULE 13G/A
Filing time
04 Feb 2025, 06:13:25 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Quoteable Key Fact

"Sumitomo Mitsui Trust Group, Inc. disclosed 4.6% ownership in ADAPTIVE BIOTECHNOLOGIES CORPORATION Common stock, par value $0.0001 per share (ADPT) on 31 Dec 2024."

Quick Takeaways

  • Sumitomo Mitsui Trust Group, Inc. filed SCHEDULE 13G/A for ADAPTIVE BIOTECHNOLOGIES CORPORATION Common stock, par value $0.0001 per share (ADPT).
  • Disclosed ownership: 4.6%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 04 Feb 2025, 06:13.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sumitomo Mitsui Trust Group, Inc. 4.6% 6,833,137 0 6,833,137 /s/ Hideaki Takamiya Senior Manager of Risk Management Dept
Nikko Asset Management Co., Ltd. 4.6% 6,833,137 0 6,833,137 /s/ Atsushi Ohya Head of Business Regulatory Compliance